Request for Information: Public Health Industrial Base Capabilities and Capacities - Essential Medicines
Closed Special Notice Posted
- Solicitation number
- 75A50225R00012
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- Place of performance
- Washington, District of Columbia, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Health and Human Services' Administration for Strategic Preparedness and Response (ASPR) has issued a Request for Information (RFI) to gather market research on domestic production capabilities and capacities for essential medicines. This RFI specifically focuses on collecting information about manufacturing capabilities for precursors, key starting materials, intermediates, active pharmaceutical ingredients, and finished dosage forms across more than 80 critical medications. The medicines of interest include acetaminophen, albuterol, various antibiotics, insulin, and other pharmaceuticals deemed essential for public health preparedness. The government has emphasized that this is strictly an information-gathering exercise and not a solicitation for proposals or quotations. The original submission deadline was extended from September 16, 2025, to September 26, 2025, at 5:00 PM Eastern Time.
The purpose of this RFI is to support the ReShoreRx initiative, which aims to build a diverse and agile public health supply chain with sustained long-term U.S. manufacturing capabilities for essential medicines. The government is seeking detailed technical information from industry partners, including regulatory holdings, production scales, manufacturing processes, equipment specifications, supply chain details, and facility capabilities. Responses must be submitted electronically to Ashlie Evans at ASPR, and all submissions will be treated as confidential and exempt from Freedom of Information Act requests. The government is particularly interested in companies that can provide population-scale solutions or rapidly scalable technologies for essential medicine production. While there are no specific eligibility criteria mentioned, the RFI targets industry partners with existing or potential domestic manufacturing capabilities who can contribute to strengthening America's pharmaceutical supply chain resilience.
Notice text
2 versions
Update #2 · Latest ·
The purpose of this revision is to ONLY extend the submission due date to 5:00pm ET on Friday, 26 September 2025.
This is NOT a Request For Proposals (RFP) or a Request For Quotations (RFQ); It is strictly a Request For Information (RFI). Neither unsolicited proposals nor any other kind of offers will be considered in response to this RFI. All interested parties should review the attachment which includes details for response.
Update #1 ·
This is NOT a Request For Proposals (RFP) or a Request For Quotations (RFQ); It is strictly a Request For Information (RFI). Neither unsolicited proposals nor any other kind of offers will be considered in response to this RFI. All interested parties should review the attachment which includes details for response.
Files
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Request for Information – Prophylactic Platform for Medical Countermeasures | ACC Aberdeen Proving Ground | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity